Upstream Processing

Jul 06, 2015
By BioPharm International Editors
Catalent licenses Excelimmune’s antibody combination therapy platform to enable the manufacture of multiple recombinant antibodies in a single batch culture.
Jul 05, 2015
By BioPharm International Editors
Biogen plans to build a biologics manufacturing plant in northwest Switzerland using next-generation technologies to create efficiency and sustainability.
Jun 29, 2015
By BioPharm International Editors
GSK will invest in an additional downstream isolation facility for amoxicillin production in Singapore.
Jun 28, 2015
By BioPharm International Editors
Australian company, Genea Biocells, will open a facility in San Diego, California for cell and culture-media manufacturing and R&D.
Jun 24, 2015
By BioPharm International Editors
Novasep's new antibody drug conjugate facility at its site in Le Mans, France will be commissioned in 2016.
Jun 24, 2015
By BioPharm International Editors
IDT Biologika acquired Aeras' vaccine manufacturing facility, and the companies will work together on tuberculosis vaccine development.
Jun 14, 2015
BioPharm International eBooks
By BioPharm International Editors
Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.
May 20, 2015
By BioPharm International Editors
Medicago's new production facility will make plant-based vaccines and therapeutics.
Apr 30, 2015
BioPharm International
Choosing the optimal protein expression vector depends on strain, promoter, and a number of other factors.
Mar 31, 2015
BioPharm International
Making the switch from batch to continuous manufacturing requires a thorough understanding of the process.